Table 4

Phenotypic analysis of a CEA-specific CTL line from patient 11a

Surface markers% positive
CD4/CD8+61.0
CD4+/CD8+37.5
CD4+/CD81.2
CD2+/CD54+92.2
CD45+/CD49d+98.1
CD11a+/CD58+98.5
CD62L/CD3+58.5
CD62L+/CD3+41.2
  • a Negative, <5% positive. Results are expressed in percentage of the CTLs reactive with the MAbs. Routinely, 2–4% of the cells were stained when treated with either no primary MAb or an isotype-match control MAb. CTL 11 cells were analyzed at IVS-8. +, positive; −, negative.